Jeff Moscow, MD

Branch Chief

Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in 2014 after serving part time since 2012, and was appointed Branch Chief in 2018. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. Dr. Moscow completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. Prior to joining CTEP, he was Children’s Miracle Network Professor of Pediatrics, Chief of Pediatric Hematology-Oncology, Vice Chair of Pediatrics, and co-leader of the Experimental Therapeutics Program of the Markey Cancer Center, all at the University of Kentucky. His IDB portfolio includes tyrosine kinase inhibitors, therapeutic antibodies and antibody-drug conjugates, and cellular therapies. He is also the program director of PDXNet, a precision medicine initiative to incorporate patient-derived models into NCI’s preclinical drug development efforts. Dr. Moscow has been awarded 5 US patents, and is an author of over 100 peer-reviewed articles, reviews, and book chapters.

Contact Information:
National Cancer Institute
9609 Medical Center Dr., MSC 9739
For USPS: Bethesda, MD 20892-9739
For Express and Courier: Rockville, MD 20850
Phone: 240-276-6565
Fax: 240-276-7894
E-mail: jeffrey.moscow@nih.gov